Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam
Reports of livestock infections with extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-E) are increasing. Based on interviews conducted over a 6-month period, we found that veterinarians in the Vietnamese province of Thai Binh prefer to prescribe colistin-based drugs (CBD) in chicken...
Gespeichert in:
Veröffentlicht in: | Tropical animal health and production 2017-01, Vol.49 (1), p.31-37 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 37 |
---|---|
container_issue | 1 |
container_start_page | 31 |
container_title | Tropical animal health and production |
container_volume | 49 |
creator | Nakayama, Tatsuya Jinnai, Michio Kawahara, Ryuji Diep, Khong Thi Thang, Nguyen Nam Hoa, Tran Thi Hanh, Le Kieu Khai, Pham Ngoc Sumimura, Yoshinori Yamamoto, Yoshimasa |
description | Reports of livestock infections with extended-spectrum beta-lactamase-producing
Escherichia coli
(ESBL-E) are increasing. Based on interviews conducted over a 6-month period, we found that veterinarians in the Vietnamese province of Thai Binh prefer to prescribe colistin-based drugs (CBD) in chicken farms. We aimed to clarify whether CBD use selects for strains of colistin-resistant ESBL-E. With the cooperation of seven local households, we detected ESBL-E in chickens’ feces after treating chickens with CBD. Phylogenetic groupings and the presence of CTX-M/AmpC genes were determined, and the multi-antibiotic susceptibility of isolates was analyzed. Our results showed that ESBL-E presented in seven chickens’ feces from two households. Seventy-two percent of ESBL-E isolates harbored CTX-M9 and the phylogenetic group A; the colistin minimum inhibitory concentration (MIC) of all isolated ESBL-E ranged from 0.064 to 1 μg mL
−1
. Moreover, ESBL-E isolates were used to experimentally select for colistin resistance, and the effect of commercial CBD on ESBL-E was investigated. The results showed that an ESBL-E strain with a colistin MIC of 4 μg mL
−1
was able to grow in media with CBD. Although CBD treatment was effective, in vitro experiments demonstrated that ESBL-E can easily acquire colistin resistance. Therefore, restrictions on colistin use are necessary to prevent the emergence of colistin-resistant bacteria. |
doi_str_mv | 10.1007/s11250-016-1154-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859480841</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859480841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-177f9ad911022c3fdaba36753702f16de1f23f3eff4c4828073b8f8c7a429b803</originalsourceid><addsrcrecordid>eNqNkc-KFDEQxoMo7rj6AF4k4MWD0fzrTvqoy64KC3pYvTbppDKT3e70mKTFeap9xc3MrCKC4Kmg6vd9RdWH0HNG3zBK1dvMGG8ooawljDWS7B6gFWuUIEoK_RCtKJUdkUqqE_Qk52tKq0q3j9EJV20rK7lCtxcJvi8QC14y4NljO48hlxDJYDI47NKyxiWBKdMeKjOGMUwhmgIYfhaIDhzJW7AlLRMeoBgyGlvMVNVkm2a32BDX-DzbDaRgN8EcNuAQ8WDszc4kh2vX3kDE3qQp7ydXGxPw-xA3-Euaf4Ro4TX-FqBEMz1Fj7wZMzy7r6fo68X51dlHcvn5w6ezd5fESsUKYUr5zriOMcq5Fd6ZwYhWNUJR7lnrgHkuvADvpZWaa6rEoL22ykjeDZqKU_Tq6FtvqP_JpZ9CtjCOJsK85J7pppOaasn-B5Wq0_rg-vIv9HpeUqyHHCihO651pdiRsmnOOYHvtylMJu16Rvt98P0x-L4G3--D73dV8-LeeRkmcL8Vv5KuAD8CuY7iGtIfq__pegcp-7uD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1854389288</pqid></control><display><type>article</type><title>Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Nakayama, Tatsuya ; Jinnai, Michio ; Kawahara, Ryuji ; Diep, Khong Thi ; Thang, Nguyen Nam ; Hoa, Tran Thi ; Hanh, Le Kieu ; Khai, Pham Ngoc ; Sumimura, Yoshinori ; Yamamoto, Yoshimasa</creator><creatorcontrib>Nakayama, Tatsuya ; Jinnai, Michio ; Kawahara, Ryuji ; Diep, Khong Thi ; Thang, Nguyen Nam ; Hoa, Tran Thi ; Hanh, Le Kieu ; Khai, Pham Ngoc ; Sumimura, Yoshinori ; Yamamoto, Yoshimasa</creatorcontrib><description>Reports of livestock infections with extended-spectrum beta-lactamase-producing
Escherichia coli
(ESBL-E) are increasing. Based on interviews conducted over a 6-month period, we found that veterinarians in the Vietnamese province of Thai Binh prefer to prescribe colistin-based drugs (CBD) in chicken farms. We aimed to clarify whether CBD use selects for strains of colistin-resistant ESBL-E. With the cooperation of seven local households, we detected ESBL-E in chickens’ feces after treating chickens with CBD. Phylogenetic groupings and the presence of CTX-M/AmpC genes were determined, and the multi-antibiotic susceptibility of isolates was analyzed. Our results showed that ESBL-E presented in seven chickens’ feces from two households. Seventy-two percent of ESBL-E isolates harbored CTX-M9 and the phylogenetic group A; the colistin minimum inhibitory concentration (MIC) of all isolated ESBL-E ranged from 0.064 to 1 μg mL
−1
. Moreover, ESBL-E isolates were used to experimentally select for colistin resistance, and the effect of commercial CBD on ESBL-E was investigated. The results showed that an ESBL-E strain with a colistin MIC of 4 μg mL
−1
was able to grow in media with CBD. Although CBD treatment was effective, in vitro experiments demonstrated that ESBL-E can easily acquire colistin resistance. Therefore, restrictions on colistin use are necessary to prevent the emergence of colistin-resistant bacteria.</description><identifier>ISSN: 0049-4747</identifier><identifier>EISSN: 1573-7438</identifier><identifier>DOI: 10.1007/s11250-016-1154-y</identifier><identifier>PMID: 27664157</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Bacterial Proteins - genetics ; beta-Lactamases - genetics ; Biomedical and Life Sciences ; Chickens ; Colistin - pharmacology ; E coli ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - veterinary ; Farms ; Feces ; Feces - microbiology ; Households ; Life Sciences ; Livestock ; Microbial Sensitivity Tests ; Phylogeny ; Poultry Diseases - drug therapy ; Poultry Diseases - microbiology ; Poultry farming ; Regular Articles ; Thailand ; Veterinary Medicine/Veterinary Science ; Vietnam ; Zoology</subject><ispartof>Tropical animal health and production, 2017-01, Vol.49 (1), p.31-37</ispartof><rights>Springer Science+Business Media Dordrecht 2016</rights><rights>Tropical Animal Health and Production is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-177f9ad911022c3fdaba36753702f16de1f23f3eff4c4828073b8f8c7a429b803</citedby><cites>FETCH-LOGICAL-c471t-177f9ad911022c3fdaba36753702f16de1f23f3eff4c4828073b8f8c7a429b803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11250-016-1154-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11250-016-1154-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27664157$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakayama, Tatsuya</creatorcontrib><creatorcontrib>Jinnai, Michio</creatorcontrib><creatorcontrib>Kawahara, Ryuji</creatorcontrib><creatorcontrib>Diep, Khong Thi</creatorcontrib><creatorcontrib>Thang, Nguyen Nam</creatorcontrib><creatorcontrib>Hoa, Tran Thi</creatorcontrib><creatorcontrib>Hanh, Le Kieu</creatorcontrib><creatorcontrib>Khai, Pham Ngoc</creatorcontrib><creatorcontrib>Sumimura, Yoshinori</creatorcontrib><creatorcontrib>Yamamoto, Yoshimasa</creatorcontrib><title>Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam</title><title>Tropical animal health and production</title><addtitle>Trop Anim Health Prod</addtitle><addtitle>Trop Anim Health Prod</addtitle><description>Reports of livestock infections with extended-spectrum beta-lactamase-producing
Escherichia coli
(ESBL-E) are increasing. Based on interviews conducted over a 6-month period, we found that veterinarians in the Vietnamese province of Thai Binh prefer to prescribe colistin-based drugs (CBD) in chicken farms. We aimed to clarify whether CBD use selects for strains of colistin-resistant ESBL-E. With the cooperation of seven local households, we detected ESBL-E in chickens’ feces after treating chickens with CBD. Phylogenetic groupings and the presence of CTX-M/AmpC genes were determined, and the multi-antibiotic susceptibility of isolates was analyzed. Our results showed that ESBL-E presented in seven chickens’ feces from two households. Seventy-two percent of ESBL-E isolates harbored CTX-M9 and the phylogenetic group A; the colistin minimum inhibitory concentration (MIC) of all isolated ESBL-E ranged from 0.064 to 1 μg mL
−1
. Moreover, ESBL-E isolates were used to experimentally select for colistin resistance, and the effect of commercial CBD on ESBL-E was investigated. The results showed that an ESBL-E strain with a colistin MIC of 4 μg mL
−1
was able to grow in media with CBD. Although CBD treatment was effective, in vitro experiments demonstrated that ESBL-E can easily acquire colistin resistance. Therefore, restrictions on colistin use are necessary to prevent the emergence of colistin-resistant bacteria.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacterial Proteins - genetics</subject><subject>beta-Lactamases - genetics</subject><subject>Biomedical and Life Sciences</subject><subject>Chickens</subject><subject>Colistin - pharmacology</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - veterinary</subject><subject>Farms</subject><subject>Feces</subject><subject>Feces - microbiology</subject><subject>Households</subject><subject>Life Sciences</subject><subject>Livestock</subject><subject>Microbial Sensitivity Tests</subject><subject>Phylogeny</subject><subject>Poultry Diseases - drug therapy</subject><subject>Poultry Diseases - microbiology</subject><subject>Poultry farming</subject><subject>Regular Articles</subject><subject>Thailand</subject><subject>Veterinary Medicine/Veterinary Science</subject><subject>Vietnam</subject><subject>Zoology</subject><issn>0049-4747</issn><issn>1573-7438</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkc-KFDEQxoMo7rj6AF4k4MWD0fzrTvqoy64KC3pYvTbppDKT3e70mKTFeap9xc3MrCKC4Kmg6vd9RdWH0HNG3zBK1dvMGG8ooawljDWS7B6gFWuUIEoK_RCtKJUdkUqqE_Qk52tKq0q3j9EJV20rK7lCtxcJvi8QC14y4NljO48hlxDJYDI47NKyxiWBKdMeKjOGMUwhmgIYfhaIDhzJW7AlLRMeoBgyGlvMVNVkm2a32BDX-DzbDaRgN8EcNuAQ8WDszc4kh2vX3kDE3qQp7ydXGxPw-xA3-Euaf4Ro4TX-FqBEMz1Fj7wZMzy7r6fo68X51dlHcvn5w6ezd5fESsUKYUr5zriOMcq5Fd6ZwYhWNUJR7lnrgHkuvADvpZWaa6rEoL22ykjeDZqKU_Tq6FtvqP_JpZ9CtjCOJsK85J7pppOaasn-B5Wq0_rg-vIv9HpeUqyHHCihO651pdiRsmnOOYHvtylMJu16Rvt98P0x-L4G3--D73dV8-LeeRkmcL8Vv5KuAD8CuY7iGtIfq__pegcp-7uD</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Nakayama, Tatsuya</creator><creator>Jinnai, Michio</creator><creator>Kawahara, Ryuji</creator><creator>Diep, Khong Thi</creator><creator>Thang, Nguyen Nam</creator><creator>Hoa, Tran Thi</creator><creator>Hanh, Le Kieu</creator><creator>Khai, Pham Ngoc</creator><creator>Sumimura, Yoshinori</creator><creator>Yamamoto, Yoshimasa</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam</title><author>Nakayama, Tatsuya ; Jinnai, Michio ; Kawahara, Ryuji ; Diep, Khong Thi ; Thang, Nguyen Nam ; Hoa, Tran Thi ; Hanh, Le Kieu ; Khai, Pham Ngoc ; Sumimura, Yoshinori ; Yamamoto, Yoshimasa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-177f9ad911022c3fdaba36753702f16de1f23f3eff4c4828073b8f8c7a429b803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacterial Proteins - genetics</topic><topic>beta-Lactamases - genetics</topic><topic>Biomedical and Life Sciences</topic><topic>Chickens</topic><topic>Colistin - pharmacology</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - veterinary</topic><topic>Farms</topic><topic>Feces</topic><topic>Feces - microbiology</topic><topic>Households</topic><topic>Life Sciences</topic><topic>Livestock</topic><topic>Microbial Sensitivity Tests</topic><topic>Phylogeny</topic><topic>Poultry Diseases - drug therapy</topic><topic>Poultry Diseases - microbiology</topic><topic>Poultry farming</topic><topic>Regular Articles</topic><topic>Thailand</topic><topic>Veterinary Medicine/Veterinary Science</topic><topic>Vietnam</topic><topic>Zoology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakayama, Tatsuya</creatorcontrib><creatorcontrib>Jinnai, Michio</creatorcontrib><creatorcontrib>Kawahara, Ryuji</creatorcontrib><creatorcontrib>Diep, Khong Thi</creatorcontrib><creatorcontrib>Thang, Nguyen Nam</creatorcontrib><creatorcontrib>Hoa, Tran Thi</creatorcontrib><creatorcontrib>Hanh, Le Kieu</creatorcontrib><creatorcontrib>Khai, Pham Ngoc</creatorcontrib><creatorcontrib>Sumimura, Yoshinori</creatorcontrib><creatorcontrib>Yamamoto, Yoshimasa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Tropical animal health and production</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakayama, Tatsuya</au><au>Jinnai, Michio</au><au>Kawahara, Ryuji</au><au>Diep, Khong Thi</au><au>Thang, Nguyen Nam</au><au>Hoa, Tran Thi</au><au>Hanh, Le Kieu</au><au>Khai, Pham Ngoc</au><au>Sumimura, Yoshinori</au><au>Yamamoto, Yoshimasa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam</atitle><jtitle>Tropical animal health and production</jtitle><stitle>Trop Anim Health Prod</stitle><addtitle>Trop Anim Health Prod</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>49</volume><issue>1</issue><spage>31</spage><epage>37</epage><pages>31-37</pages><issn>0049-4747</issn><eissn>1573-7438</eissn><abstract>Reports of livestock infections with extended-spectrum beta-lactamase-producing
Escherichia coli
(ESBL-E) are increasing. Based on interviews conducted over a 6-month period, we found that veterinarians in the Vietnamese province of Thai Binh prefer to prescribe colistin-based drugs (CBD) in chicken farms. We aimed to clarify whether CBD use selects for strains of colistin-resistant ESBL-E. With the cooperation of seven local households, we detected ESBL-E in chickens’ feces after treating chickens with CBD. Phylogenetic groupings and the presence of CTX-M/AmpC genes were determined, and the multi-antibiotic susceptibility of isolates was analyzed. Our results showed that ESBL-E presented in seven chickens’ feces from two households. Seventy-two percent of ESBL-E isolates harbored CTX-M9 and the phylogenetic group A; the colistin minimum inhibitory concentration (MIC) of all isolated ESBL-E ranged from 0.064 to 1 μg mL
−1
. Moreover, ESBL-E isolates were used to experimentally select for colistin resistance, and the effect of commercial CBD on ESBL-E was investigated. The results showed that an ESBL-E strain with a colistin MIC of 4 μg mL
−1
was able to grow in media with CBD. Although CBD treatment was effective, in vitro experiments demonstrated that ESBL-E can easily acquire colistin resistance. Therefore, restrictions on colistin use are necessary to prevent the emergence of colistin-resistant bacteria.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>27664157</pmid><doi>10.1007/s11250-016-1154-y</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-4747 |
ispartof | Tropical animal health and production, 2017-01, Vol.49 (1), p.31-37 |
issn | 0049-4747 1573-7438 |
language | eng |
recordid | cdi_proquest_miscellaneous_1859480841 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Anti-Bacterial Agents - pharmacology Bacterial Proteins - genetics beta-Lactamases - genetics Biomedical and Life Sciences Chickens Colistin - pharmacology E coli Escherichia coli Escherichia coli - drug effects Escherichia coli Infections - drug therapy Escherichia coli Infections - veterinary Farms Feces Feces - microbiology Households Life Sciences Livestock Microbial Sensitivity Tests Phylogeny Poultry Diseases - drug therapy Poultry Diseases - microbiology Poultry farming Regular Articles Thailand Veterinary Medicine/Veterinary Science Vietnam Zoology |
title | Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T20%3A36%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frequent%20use%20of%20colistin-based%20drug%20treatment%20to%20eliminate%20extended-spectrum%20beta-lactamase-producing%20Escherichia%20coli%20in%20backyard%20chicken%20farms%20in%20Thai%20Binh%20Province,%20Vietnam&rft.jtitle=Tropical%20animal%20health%20and%20production&rft.au=Nakayama,%20Tatsuya&rft.date=2017-01-01&rft.volume=49&rft.issue=1&rft.spage=31&rft.epage=37&rft.pages=31-37&rft.issn=0049-4747&rft.eissn=1573-7438&rft_id=info:doi/10.1007/s11250-016-1154-y&rft_dat=%3Cproquest_cross%3E1859480841%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1854389288&rft_id=info:pmid/27664157&rfr_iscdi=true |